(Q53128744)
Statements
DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice. (English)
Cristina Müller
Harriet Struthers
Christian Winiger
Konstantin Zhernosekov
12 December 2012
54
1
124-131